US Stocks
/
Genelux Corporation Share Price

Genelux Corporation Share Price

NASDAQ: GNLX | Micro Cap
$2.57
+$0.06 (2.59%) Last updated on 10 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Genelux Corporation Stock Performance

Open
$2.54
Prev. Close
$2.50
Circuit Range
N/A
Day Range
$2.48 - $2.56
Year Range
$2.29 - $8.46
Volume
11,378
Average Traded
$2.50

Genelux Corporation Share Price Today

As of 11 October 2026, Genelux Corporation's share price is $2.57. The stock opened at $2.54, compared to its previous close of $2.50. During today's trading session, Genelux Corporation's share price traded between $2.48 and $2.56, with an average price of $2.52. Over the past 52 weeks, the stock has recorded a high of $8.46 and a low of $2.29. In terms of performance, Genelux Corporation's share price has declined by 3.56% over the last six months and is down 68.15% on a year-on-year basis.

Genelux Corporation Share Price Chart

$2.48$2.56
L
Show Current Price
H

Genelux Corporation Stock Fundamentals & Key Indicators

Market Cap
$95.54M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.79
Revenue (TTM)
$10.00M
Return On Equity (TTM)
-220.91%
Profit Margin
-321500.00%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-19.12%

Genelux Corporation Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.01$0.00$0.00
Net Profit-$7.95-$9.25-$8.93-$9.47
Net Profit MarginN/A-92500.00%N/AN/A
Income ChangeN/A-16.35%3.46%-6.05%

Genelux Corporation Annual Profit & Loss

All figures in USD

Particulars202320242025
Revenue$0.17$0.01$0.01
Net Profit-$28.30-$29.87-$32.15
Net Profit Margin-16647.06%-298700.00%-321500.00%
Income ChangeN/A-5.55%-7.63%

About Genelux Corporation

Genelux Corp is a late-stage biopharmaceutical firm focused on developing oncolytic viral immunotherapies for cancer. Its pipeline includes clinical and preclinical candidates designed to target tumor cells and stimulate an immune response against tumor-specific antigens. The company is focused on the development of next-generation oncolytic viral immunotherapies that are designed to generate a personalized multi-prong attack to overwhelm a tumor's sophisticated defense mechanisms.

Genelux Corporation Historical Returns

MonthOpenCloseChange %
Oct 2026
$2.48
$2.56
+0.99%
Sep 2026
$2.58
$2.53
-12.15%
Aug 2026
$2.96
$2.88
-1.87%
Jul 2026
$3.01
$2.94
-2.81%
Jun 2026
$3.00
$3.02
-1.31%
May 2026
$2.67
$3.06
+14.82%
Apr 2026
$2.48
$2.67
+10.58%
Mar 2026
$2.84
$2.41
-19.13%
Feb 2026
$2.73
$2.98
+11.61%
Jan 2026
$4.54
$2.67
-38.69%
Dec 2025
$5.25
$4.36
-22.30%
Nov 2025
$7.92
$5.61
-30.55%

GNLX Share Price FAQs

What is Genelux Corporation share price today?

chevron-up
Genelux Corporation share price today is $2.57 as on October 10, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Genelux Corporation stock?

chevron-up
The 52 week high of Genelux Corporation stock is $8.46, while the 52 week low is $2.29 as of 10 Oct '26.

What is GNLX's market capitalisation today?

chevron-up
GNLX market capitalisation is $95.54M as of October 11, 2026, at 2:06 am IST.

What is GNLX's net income for the last quarter?

chevron-up
GNLX's net income for the last quarter is -9.47B USD.

What is the 5 year returns of GNLX?

chevron-up
The 5 year returns of GNLX is -55.12% as on 10 Oct '26.

What is the high & low stock price of GNLX today?

chevron-up
GNLX stock price hit a high of $2.56 and low of $2.48 as of 10 Oct '26.

Can I buy GNLX shares in India?

chevron-up
Yes. You can buy GNLX in India by opening an international trading account.